SEP 25, 2015 3:13 PM PDT

New Drug and Native Flora Combat C. difficile

WRITTEN BY: Kerry Evans
Clostridium difficile is a Gram positive, rod-shaped bacterium commonly found in the soil.  However, a small number of people, about 1 in 20, also house C. difficile in their guts. This usually isn’t a problem, but the bacteria can produce toxins that cause severe cases of colitis, diarrhea, and sometimes death. These infections typically occur in cases where the normal gut flora has been depleted by antibiotics, allowing C. difficile to “take over”.   

Since antibiotics often promote C. difficile infections, they aren’t much use in combating these bacteria. This has left researchers searching for other treatment options, and scientists at Stanford University School of Medicine have taken a unique approach.
 
C. difficile infection causes severe colitis and diarrhea.


Instead of searching for a way to kill C. difficile directly, Matthew Bogyo, Ph.D., used a small molecule called ebselen to disarm C. difficile toxins.  These toxins enter the cells lining the gut and induce an inflammatory response, resulting in colitis and diarrhea.  This proinflammatory response also prevents the normal flora from repopulating the gut.  

Bogyo and colleagues showed that ebselen had a direct effect on the activity of C. difficile toxins by incubating purified toxin with or without ebselen, and then injecting the mixtures into mice.  After three days, all of the mice injected with toxin alone died, while the mice injected with the ebselen and toxin mixture survived.  Bogyo then tested a more clinically relevant model of infection.  They first treated mice with antibiotics to mimic the conditions under which C. difficile infections occur.  Following antibiotic treatment, they infected mice with a highly virulent, drug-resistant strain of C. difficile, and treated them orally with ebselen.  The mice treated with ebselen survived the infection with little evidence of damage to the colon.  

Thus, ebselen both prevented damaging colitis and diarrhea, and allowed the normal flora to outcompete C. difficile.  What’s more, ebselen has already been tested in clinical trials to treat hearing loss in chemotherapy patients.  This means ebselen could be on the fast track to treating C. difficile infections.  

Ebselen isn’t the only unique approach to treating C. difficile. Fecal transplant, as explained in this video, has been highly successful in treating C. difficile infections.  

Sources: Science Daily, Science Translational Medicine, Wikipedia, Cleveland Clinic
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
JUN 24, 2020
Neuroscience
Prenatal Stress May Influence Infant Gut Bacteria
JUN 24, 2020
Prenatal Stress May Influence Infant Gut Bacteria
Although prenatal stress has previously been associated with infant growth and development, exactly how they are linked ...
JUL 12, 2020
Microbiology
Our Flu Response Is Influenced by Previous Exposures
JUL 12, 2020
Our Flu Response Is Influenced by Previous Exposures
The flu is caused by a respiratory virus, which evolves from year to year. Three kinds of influenza viruses infect human ...
AUG 23, 2020
Microbiology
How Microbes Can Help Clean a Toxic River
AUG 23, 2020
How Microbes Can Help Clean a Toxic River
Some places in the United States have become dangerously polluted with hazardous waste. The EPA oversees a program that ...
AUG 24, 2020
Microbiology
Microbes That Live on Air Alone Found Outside of Antarctica
AUG 24, 2020
Microbes That Live on Air Alone Found Outside of Antarctica
In 2017, researchers reported that they had identified microbes in Antarctica that could basically survive on only air. ...
SEP 04, 2020
Microbiology
Researchers Discover a Way to Use Microbes to Help Make Plastic
SEP 04, 2020
Researchers Discover a Way to Use Microbes to Help Make Plastic
Researchers have discovered that some bacteria can make ethylene in a way we never knew about; microbes that metabolize ...
SEP 10, 2020
Clinical & Molecular DX
Microscope to Diagnose River Blindness Is a Winner
SEP 10, 2020
Microscope to Diagnose River Blindness Is a Winner
  A team of innovators from Stanford University has invented the Onchoscope: a low-cost, customizable microscope fo ...
Loading Comments...